BioWorld - Tuesday, July 28, 2026 See today's BioWorld Home Microbiota modulates the antidepressant effects of GLP-1 analogues Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on the GLP-1 receptor but instead on the gut microbiota, since the treatment increases the presence of the bacterium Lactobacillus delbrueckii
The Court also found that it will be pivotal to focus early in the litigation on whether plaintiffs must provide gastroparesis diagnostic testing to reliably establish they had the injury, which is expected to be the claimed diagnosis in over 95% of the Ozempic lawsuits
While Semaglutide was originally developed for type 2 diabetes, its FDA-approved specifically for weight loss in non-diabetic patients
When asked what most naked mole rats do die of, she throws her hands up
Bangladesh Journal of Pharmacology 10: 152-159
Understanding its causes and manifestations helps professionals and ordinary people balance healthy attention-seeking behavior and its destructive forms